The Government of India has limited retail prices of medical devices such as knee implants and heart stents by up to 75 percent to make them more affordable, but the $5 billion Indian medical-technology industry that includes Abbott Laboratories, Boston Scientific Corp, and Johnson & Johnson, among others, has protested these...